Yong'an Pharmaceutical Co., Ltd. (Stock Code: 002365)
Announcement No.: 2026-31
This company and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder: According to the Company Law and the Shenzhen Stock Exchange Self-Regulatory Guidelines No. 9 on Share Repurchase, Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") does not have the right to participate in profit distribution for shares held in the repurchase special securities account.
This equity distribution is based on the existing total share capital of 294,682,500 shares, minus the 5,537,350 shares held in the repurchase special securities account, resulting in a base of 289,145,150 shares. A cash dividend of 1.00 RMB (including tax) will be distributed for every 10 shares to all shareholders, with no bonus shares or capital increase from reserves. The total cash distribution amounts to 28,914,515.00 RMB (including tax).
Since the shares held in the repurchase special securities account do not participate in the equity distribution, and the total share capital remains unchanged before and after the distribution, the proportion of the total cash dividend allocated to each share will decrease. Therefore, after the implementation of this equity distribution, the calculation of the ex-dividend price will be based on a cash dividend of 0.981209 RMB for every 10 shares (calculated as total cash dividend / total share capital × 10, i.e., 0.981209 RMB = 28,914,515.00 RMB ÷ 294,682,500 shares × 10, with six decimal places retained and the last digit truncated). Thus, the cash dividend per share will be calculated as 0.0981209 RMB/share. The ex-dividend price after the implementation of the 2025 annual equity distribution will be calculated as the closing price on the record date minus 0.0981209 RMB/share.